Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000013

CEO bought 17,000 shares at an average $0.02 ($389)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-15 Purchase : show line 1 in the form +4,000 $0.02 $90 21,540,123 D
2019-02-15 Purchase : show line 2 in the form +1,000 $0.02 $23 21,541,123 D
2019-02-15 Purchase : show line 3 in the form +2,000 $0.02 $46 21,543,123 D
2019-02-15 Purchase : show line 4 in the form +10,000 $0.02 $230 21,553,123 D
Open-market purchases · 17,000 sh · avg $0.02 · $389
Loading xslF345X03/primary_doc.xml…